Submitted by Anonymous (not verified) on 13 May 2026 - 15:15
Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 29, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 29, Status: Authorised